Needle-free diabetes care: 7 devices that painlessly monitor blood sugar
Will the daily routine of finger pricking to monitor blood sugar levels finally come to…
October 7, 2022 - 6 minutes
Roche
Roche launches next-generation SARS-CoV-2 Rapid Antibody Test
Roche has launched the SARS-CoV-2 Rapid Antibody Test 2.0 in markets accepting the CE Mark. …
October 3, 2022 - 4 minutes
Ghana first to benefit from Roche partnership with Jhpiego to improve cervical and breast cancer outcomes for women
Roche has signed a memorandum of understanding (MoU) with the Johns Hopkins Program for International…
September 16, 2022 - 3 minutes
New research boosts Nordic Bioscience’s PRO-C6 as biomarker assay for trial enrichment in HFpEF
The New England Journal of Medicine Evidence (NEJME) has published research that further establishes and…
September 15, 2022 - 3 minutes
Roche launches COVID-19 test to detect emerging variant of interest
Roche and its subsidiary TIB Molbiol have developed a COVID-19 test for researchers that detects…
August 22, 2022 - 2 minutes
Roche announces influenza drug approval and new COVID test
Roche has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental…
August 15, 2022 - 6 minutes
The Future of Diabetes Treatment: Is a Cure Possible?
Diabetes has become an epidemic, sentencing over 460 million people worldwide to lifelong medication. Science…
November 15, 2021 - 10 minutes
EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
April 27, 2021 - 6 minutes
Roche Confirms Pharma Appetite for Inflammatory Disease Treatments
Roche’s acquisition of the Irish biotech Inflazome is a vote of confidence for emerging inflammatory…
September 25, 2020 - 4 minutes
European Project Launches to Tailor Autoimmune Disease Treatments
Public and private organizations across Europe will pool their resources in an €80M project to…
October 31, 2019 - 2 minutes
Why Clinical Trial Design Can Make or Break Your Company
Andreas Wallnöfer spent over 20 years working on drug development at Roche before moving to…
May 23, 2019 - 7 minutes
AI Drug Discovery Company Raises €23M and Signs with Roche
Oxford-based Exscientia has closed a €23M ($26M) Series B round and announced a partnership with…
January 7, 2019 - 2 minutes
